Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Ingegnoli

Showing results (41-50 of 146) with videos related to

Pageof 15
Sort By:
Clinical and Experimental Rheumatology|April 19, 2016
Prothrombotic biomarkers in patients with rheumatoid arthritis: the beneficial effect of IL-6 receptor blockadeRoberta Gualtierotti, Francesca Ingegnoli, Samantha Griffini, et al.
Clinical Reviews in Allergy & Immunology|June 5, 2017
Cutaneous Manifestations of ANCA-Associated Small Vessels VasculitisAngelo Valerio Marzano, Maria Gabriella Raimondo, Emilio Berti, et al.
Autoimmunity Reviews|October 12, 2011
Interstitial lung disease outcomes by high-resolution computed tomography (HRCT) in Anti-Jo1 antibody-positive polymyositis patients: a single centre study and review of the literatureFrancesca Ingegnoli, Chiara Lubatti, Anna Ingegnoli, et al.
Rheumatology (Oxford, England)|March 15, 2018
The patient experience of Raynaud's phenomenon in systemic sclerosisJohn D Pauling, Lesley Ann Saketkoo, Marco Matucci-Cerinic, et al.
Rheumatology (Oxford, England)|May 8, 2018
Acute and chronic effects of two different intravenous iloprost regimens in systemic sclerosis: a pragmatic non-randomized trialTommaso Schioppo, Annalisa Orenti, Patrizia Boracchi, et al.
Arthritis Research & Therapy|September 17, 2024
Truth unveiled by time and the marbled definition of D2T-RA: retrospective analysis on the persistence of the difficult-to-treat status among refractory RA patientsGilberto Cincinelli, Gabriella Maioli, Cristina Posio, et al.
Microvascular Research|July 9, 2018
Evidence of macro- and micro-angiopathy in scleroderma: An integrated approach combining 22-MHz power Doppler ultrasonography and video-capillaroscopyTommaso Schioppo, Annalisa Orenti, Patrizia Boracchi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 8, 2020
Incidence of COVID-19 in Patients With Rheumatic Diseases Treated With Targeted Immunosuppressive Drugs: What Can We Learn From Observational Data?Ennio Giulio Favalli, Sara Monti, Francesca Ingegnoli, et al.
Clinical Rheumatology|November 28, 2007
Reliability and validity of the Italian version of the hand functional disability scale in patients with systemic sclerosisFrancesca Ingegnoli, Valentina Galbiati, Patrizia Boracchi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2002
Annexin 1 modulates monocyte-endothelial cell interaction in vitro and cell migration in vivo in the human SCID mouse transplantation modelMauro Perretti, Francesca Ingegnoli, Samantha K Wheller, et al.
Pageof 15

Showing results (41-50 of 146) with videos related to

Sort By:
Pageof 15
Clinical and Experimental Rheumatology|April 19, 2016
Prothrombotic biomarkers in patients with rheumatoid arthritis: the beneficial effect of IL-6 receptor blockadeRoberta Gualtierotti, Francesca Ingegnoli, Samantha Griffini, et al.
Clinical Reviews in Allergy & Immunology|June 5, 2017
Cutaneous Manifestations of ANCA-Associated Small Vessels VasculitisAngelo Valerio Marzano, Maria Gabriella Raimondo, Emilio Berti, et al.
Autoimmunity Reviews|October 12, 2011
Interstitial lung disease outcomes by high-resolution computed tomography (HRCT) in Anti-Jo1 antibody-positive polymyositis patients: a single centre study and review of the literatureFrancesca Ingegnoli, Chiara Lubatti, Anna Ingegnoli, et al.
Rheumatology (Oxford, England)|March 15, 2018
The patient experience of Raynaud's phenomenon in systemic sclerosisJohn D Pauling, Lesley Ann Saketkoo, Marco Matucci-Cerinic, et al.
Rheumatology (Oxford, England)|May 8, 2018
Acute and chronic effects of two different intravenous iloprost regimens in systemic sclerosis: a pragmatic non-randomized trialTommaso Schioppo, Annalisa Orenti, Patrizia Boracchi, et al.
Arthritis Research & Therapy|September 17, 2024
Truth unveiled by time and the marbled definition of D2T-RA: retrospective analysis on the persistence of the difficult-to-treat status among refractory RA patientsGilberto Cincinelli, Gabriella Maioli, Cristina Posio, et al.
Microvascular Research|July 9, 2018
Evidence of macro- and micro-angiopathy in scleroderma: An integrated approach combining 22-MHz power Doppler ultrasonography and video-capillaroscopyTommaso Schioppo, Annalisa Orenti, Patrizia Boracchi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 8, 2020
Incidence of COVID-19 in Patients With Rheumatic Diseases Treated With Targeted Immunosuppressive Drugs: What Can We Learn From Observational Data?Ennio Giulio Favalli, Sara Monti, Francesca Ingegnoli, et al.
Clinical Rheumatology|November 28, 2007
Reliability and validity of the Italian version of the hand functional disability scale in patients with systemic sclerosisFrancesca Ingegnoli, Valentina Galbiati, Patrizia Boracchi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2002
Annexin 1 modulates monocyte-endothelial cell interaction in vitro and cell migration in vivo in the human SCID mouse transplantation modelMauro Perretti, Francesca Ingegnoli, Samantha K Wheller, et al.
Pageof 15